Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Nurr1 reduction influences the onset of chronic EAE in mice.
Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury.
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
Charcot-Marie-Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups.
Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.
Slowing of information processing speed without motor slowing in multiple sclerosis observed during two crossing-off tasks.
Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseases.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Use of imaging to study leukocyte trafficking in the central nervous system.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
Fine-Tuning of Regulatory T Cell Function: The Role of Calcium Signals and Naive Regulatory T Cells for Regulatory T Cell Deficiency in Multiple Sclerosis.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Pages
« first
‹ previous
…
404
405
406
407
408
409
410
411
412
…
next ›
last »